Search
Selected: N

Nonapeptide and decapeptide analogs of LHRH useful as LHRH antag

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Nonapeptide and decapeptide analogs of LHRH, useful as LHRH anta

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Nonapeptide and decapeptide analogs of LHRH, useful as LHRH anta

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Nonapeptide and decapeptide derivatives of luteinizing hormone r

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Nonapeptide for treating addictive drug withdrawal conditions

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Nonapeptide having immunostimulative activity, process for the p

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Nonapeptide, a process for its preparation, an agent containing

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Nonapeptides

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel antagonists of the antidiuretic action of arginine vasopre

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel antagonists of the antidiuretic and/or vasopressor action

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel anticoagulant agmatine derivatives and process for the pre

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel biological substance from a fungus and the process for pro

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel compounds, compositions and methods of their use

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel cyclopeptides

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel derivatives of beta-endorphin, intermediates therefor and

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel derivatives of pepstatin, their preparation and compositio

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel enkephalin analogs and process for the preparation thereof

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel glycoproteins

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel lipophilic muramyl peptides and processes for their manufa

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel pentapeptides, processes for their production, pharmaceuti

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.